1Lewis GF, Carpentier A, Adeli K, et al. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev, 2002,23 (2) :201-229.
2Bouloumie A, Curat CA, Sengenes C, et al. Role of macrophage tissue infiltration in metabolic diseases. Curr Opin Clin Nutr Metab Care, 2005,8(4) :347-354.
3Gedo S, Verdood P, Hooghe-Peters EL, et al. Multiple, PKA-dependent and PKA-independent, signals are involved in cAMP-indueed PRL expression in the eoxinophilie cell line Eol-1. Cell Signal, 2005,17(7) :901-909.
4Viengchareun S, Bouzinba-Segard H, Laigneau JP, et al. Porlactin potentiates insulin-stimulated leptin expression and release from differentiated brown adipoeytes. J Mol Endocrinol, 2004, 33 ( 3 ) : 679-691.
5Stewart WC, Baugh JE Jr, Floyd ZE, et al. STAT5 activators can replace the requirement of FBS in the adipogenesis of 3T3-L1 cells. Biochem Biophys Res Commun, 2004,324( 1 ) :355-359.
6Ling C, Sversson L, Oden B, et al. Identification of functional prolactin(PRL) receptor gene expression : PRL inhibits lipoprotein lipase activity in human white adipose tissue. J Clin endocrinol Metab, 2003,88 (4) :1804-1808.
7Lapensee CR, Horseman ND, Tso P, et al. The prolactin deficient mouse has an unaltered metabolic phenotype. Endocrinology, 2006, 147 (10) :4638-4648.
8Nilsson L, Binart N, Bohlooly Y, et al. Prolaetin and growth hormone regulate adiponectin secretion and receptor expression in adipose tissue. Biochem biophys Res Commun, 2005,331 (4) :1120-1126.
9Hugo ER, Brandebourg TD, Comstock CE, et al. LS14 : a novel human adipocyte cell line that produces prolactin. Endocrinology, 2006,147(1) :306-313.
